Kidney Health Initiative (KHI)

Kidney Innovation Conference
2026-05-20 - 2026-05-21 | Grand Hyatt Washington DC, 1000 H Street NW, Washington, DC, 20001, United States
This annual meeting brings together innovators, patients, care partners, industry, policymakers, and entrepreneurs from across the kidney community. The 2026 agenda will feature:

Dynamic networking sessions designed to foster meaningful connections
In-depth workshops that dive deeper into critical challenges facing the kidney community
Engaging panels and sessions highlighting cutting-edge innovation
Keynote remarks from leading innovators in the space

Please note that registration closes Monday, May 18, 2026, and housing closes Wednesday, April 29, 2026.

KHI April Mixer: Aligning on a Pathway for Novel Immunosuppression Drugs for Transplantation
2026-04-13 16:00 - 17:00 (America/New_York) | Virtual
Join the Kidney Health Initiative (KHI) for an informal virtual discussion on opportunities to evaluate clinical trial endpoints for transplant immunosuppression drugs.
KHI is planning a pre-competitive and collaborative project to catalyze the development of novel immunosuppression drugs, given the limited choices available for transplant recipients. KHI seeks feedback to ensure that a collaborative solution addresses the stagnation in this space.
Don’t miss this opportunity to share your thoughts and perspectives on aligning the pathway for transplant immunosuppression endpoints.
Register Now!

Advancing the Therapeutic Pipeline in Alport Syndrome
2026-03-23 16:00 - 17:00 UTC
Join the Kidney Health Initiative (KHI) for a mixer focused on the future of Alport syndrome therapies. Alport Syndrome Foundation will share updates from their December 2025 FDA campus meeting focused on ASSENT (Alport Syndrome Surrogate Endpoint Network), an international initiative with the goal of identifying surrogate endpoints that can be used in clinical trials to accelerate drug development and bring new therapies to patients with Alport syndrome. This session will highlight the status of the pharmaceutical pipeline in Alport syndrome, key challenges and opportunities in drug development for this rare genetic kidney disease, and how this patient organization is partnering with industry at every stage—from preclinical exploration to clinical trial design and patient recruitment. Don’t miss this opportunity to hear the latest insights and connect with others committed to accelerating treatments for the Alport community.

Showcasing KHI’s 2026 Project Portfolio
2026-02-19 12:00 - 13:00 (America/New_York)
Join KHI for the first webinar of 2026, featuring an in-depth look at our diverse project portfolio and how each initiative advances KHI’s strategic plan. Through project highlights and updates from committee leads and project champions, attendees will gain insight into KHI’s ongoing impact and future direction. The session will emphasize cross-collaboration, showcase achievements, and invite engagement from the broader KHI community as we work collectively toward innovation, equity, and improved patient outcomes in kidney health.

Welcoming New Voices and Shaping KHI’s 2026 Vision
2026-01-26 16:00 - 17:00 UTC
The January KHI Mixer kicks off the new year by welcoming incoming Board of Directors members and setting the stage for KHI’s 2026 priorities. This informal session will spotlight how KHI’s strategic plan translates into actionable initiatives and community engagement throughout the year. Attendees will hear updates on upcoming projects, committee goals, and opportunities to collaborate in advancing innovation in kidney health. Through open discussion and connection, participants will help shape KHI’s direction for a successful and impactful year ahead.
